Pulse Biosciences (PLSE) Retained Earnings (2015 - 2025)

Pulse Biosciences' Retained Earnings history runs 11 years deep, the most recent figure standing at -$463.3 million for Q4 2025.

• On a quarterly basis, Retained Earnings fell 18.64% year-over-year to -$463.3 million in Q4 2025; TTM through Dec 2025 was -$463.3 million, a 18.64% decrease from a year earlier, with the FY2025 full-year figure at -$463.3 million, down 18.64% from the prior year.
• Retained Earnings eased to -$463.3 million in Q4 2025 per PLSE's latest filing, from -$445.8 million in the prior quarter.
• Across five years, Retained Earnings topped out at -$191.2 million in Q1 2021 and bottomed at -$463.3 million in Q4 2025.
• The 5-year median for Retained Earnings is -$314.7 million (2023), against an average of -$322.0 million.
• Across the five-year window, Retained Earnings plunged 1124682.35% in 2021 and fell 13.83% in 2023, its largest moves.
• Year by year, Retained Earnings stood at -$220.8 million in 2021, then sank by 33.47% to -$294.7 million in 2022, then retreated by 10.27% to -$325.0 million in 2023, then retreated by 20.16% to -$390.5 million in 2024, then decreased by 18.64% to -$463.3 million in 2025.
• Per Business Quant, the three latest PLSE Retained Earnings figures stand at -$463.3 million (Q4 2025), -$445.8 million (Q3 2025), and -$426.5 million (Q2 2025).